Reference page — cumulative record through Sunday, October 4, 2026 UTC. Reference pages update as the archive grows; only dated daily editions are immutable pages of record.
Traefik
Product reference — Traefik by Traefik · sector: Other. Cumulative disclosure record for this product across the archive.
Product totals
| All-time | YTD | |
|---|---|---|
| CVEs | 32 | 32 |
| KEV entries | 0 | 0 |
| KEV/100 | Med CVSS | Med EPSS | C | H | M | L |
|---|---|---|---|---|---|---|
| 0.0 | 7.0 | .0046 | 3 | 15 | 13 | 1 |
KEV/100 = KEV entries ÷ CVEs × 100. Med CVSS / Med EPSS are medians over this product's disclosures. C/H/M/L = disclosures by CVSS severity band.
Monthly disclosures
Trend (by first-seen month, full archive): ▂▄▄▄█▁
| Month | New CVEs |
|---|---|
| 2026-05 | 1 |
| 2026-06 | 6 |
| 2026-07 | 6 |
| 2026-08 | 5 |
| 2026-09 | 14 |
| 2026-10 | 0 |
Notable CVEs
Ranked by the published formula: KEV → EPSS → CVSS → CVE ID.
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-48020 | 7.8 | 54.2 | HIGH | — | 2026-06-23 |
| CVE-2023-54365 | 8.7 | 54.2 | HIGH | — | 2026-06-23 |
| CVE-2026-71324 | 7.0 | 51.2 | HIGH | — | 2026-08-06 |
| CVE-2026-85595 | 9.3 | 51.2 | CRITICAL | — | 2026-09-04 |
| CVE-2026-88010 | 6.3 | 51.2 | MEDIUM | — | 2026-09-22 |
| CVE-2026-67309 | 7.8 | 49.8 | HIGH | — | 2026-08-01 |
| CVE-2026-88877 | 9.3 | 49.3 | CRITICAL | — | 2026-09-10 |
| CVE-2026-53622 | 7.8 | 48.3 | HIGH | — | 2026-06-23 |
| CVE-2026-65600 | 7.8 | 48.0 | HIGH | — | 2026-07-22 |
| CVE-2026-88007 | 9.1 | 46.9 | CRITICAL | — | 2026-09-10 |
| CVE-2026-44774 | 6.4 | 44.1 | MEDIUM | — | 2026-05-15 |
| CVE-2026-88012 | 5.3 | 41.8 | MEDIUM | — | 2026-09-10 |
| CVE-2026-65601 | 5.3 | 41.6 | MEDIUM | — | 2026-07-22 |
| CVE-2026-88008 | 7.0 | 39.8 | HIGH | — | 2026-09-10 |
| CVE-2026-71327 | 7.6 | 39.3 | HIGH | — | 2026-08-06 |
Recent CVEs
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-88010 | 6.3 | 51.2 | MEDIUM | — | 2026-09-22 |
| CVE-2026-88011 | 5.3 | 34.1 | MEDIUM | — | 2026-09-10 |
| CVE-2026-88012 | 5.3 | 41.8 | MEDIUM | — | 2026-09-10 |
| CVE-2026-88877 | 9.3 | 49.3 | CRITICAL | — | 2026-09-10 |
| CVE-2026-88878 | 6.9 | 34.4 | MEDIUM | — | 2026-09-10 |
| CVE-2026-88879 | 5.3 | 20.1 | MEDIUM | — | 2026-09-10 |
| CVE-2026-88004 | 7.0 | 37.1 | HIGH | — | 2026-09-10 |
| CVE-2026-88009 | 8.8 | 36.3 | HIGH | — | 2026-09-10 |
| CVE-2026-88007 | 9.1 | 46.9 | CRITICAL | — | 2026-09-10 |
| CVE-2026-88008 | 7.0 | 39.8 | HIGH | — | 2026-09-10 |
| CVE-2026-85596 | 8.2 | 35.6 | HIGH | — | 2026-09-04 |
| CVE-2026-85594 | 7.0 | 39.0 | HIGH | — | 2026-09-04 |
| CVE-2026-85597 | 8.2 | 26.5 | HIGH | — | 2026-09-04 |
| CVE-2026-85595 | 9.3 | 51.2 | CRITICAL | — | 2026-09-04 |
| CVE-2026-71326 | 2.1 | 24.8 | LOW | — | 2026-08-06 |
KEV entries
No entries in the CISA KEV catalog.
Related
Vendor: Traefik — all products and the full vendor record.
Methodology
A product is a (vendor, product) pair as named in the affected-product data. Rate statistics are arithmetic over published figures. Counts key to first-seen day. Raw counts are not comparable across products; this is a reference page assembled from the public record, not a ranking by our judgment.
Sources. CVE Program (cvelistV5), NVD (NIST), CISA KEV, FIRST EPSS.
